drugset / Trial / NCT04289948

Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes

NCT04289948 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Work Package 1: Observational cohort pilot safety study Work Package 2: Randomised, double-blind, placebo controlled pilot study Work Package 3: Observer-blind pilot RCT

Timeline

Start
2019-03-01
Primary completion
2022-06-01
Completion
2022-09-01

Outcome

Outcome not reported

Stopped (Business): “Funding issues meant that development of the study was halted.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Phage Other / unclassified 5 ml Topical

Indications